Meda BioTech, Inc.

Meda Biotech, LLC was founded in 2003 on the strength of a conviction that a new concept, HYBRID-NANOENGINEERINGTM, could solve insolubility problems and have real therapeutic value for patients. That belief gave birth to a process of continual discovery and innovation, allowing it to give birth to many innovative medicines. Since 2002, Meda Biotech has been working to commercialize a technology that could make treatment more effective and less harmful to patients, especially for the treatment of cancer, pain and inflammation.